Bri-Chem Corp. (TSX:BRY)
Canada flag Canada · Delayed Price · Currency is CAD
0.3200
-0.0600 (-15.79%)
Aug 1, 2025, 11:40 AM EDT

Regulus Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
81091742
Upgrade
Market Cap Growth
-9.86%10.77%-50.76%370.29%93.82%-20.00%
Upgrade
Enterprise Value
303245522314
Upgrade
Last Close Price
0.320.360.330.660.150.08
Upgrade
PE Ratio
--9.452.022.82-
Upgrade
PS Ratio
0.100.120.080.170.060.04
Upgrade
PB Ratio
0.440.490.380.780.320.18
Upgrade
P/TBV Ratio
0.440.490.380.780.320.18
Upgrade
P/FCF Ratio
0.720.950.72--0.19
Upgrade
P/OCF Ratio
0.700.920.68--0.19
Upgrade
PEG Ratio
-0.200.200.200.200.20
Upgrade
EV/Sales Ratio
0.370.390.430.500.370.31
Upgrade
EV/EBITDA Ratio
52.21-8.947.556.78-
Upgrade
EV/EBIT Ratio
--10.308.277.91-
Upgrade
EV/FCF Ratio
2.573.233.79--1.37
Upgrade
Debt / Equity Ratio
1.141.251.401.772.041.20
Upgrade
Debt / EBITDA Ratio
37.5952.845.555.346.31-
Upgrade
Debt / FCF Ratio
1.852.452.64--1.24
Upgrade
Asset Turnover
1.361.311.441.711.721.26
Upgrade
Inventory Turnover
2.692.582.883.473.432.48
Upgrade
Quick Ratio
0.590.470.650.650.610.79
Upgrade
Current Ratio
1.361.121.421.321.162.12
Upgrade
Return on Equity (ROE)
-13.50%-18.27%4.05%50.66%11.82%-38.77%
Upgrade
Return on Assets (ROA)
-0.72%-0.81%3.75%6.46%5.08%-4.78%
Upgrade
Return on Capital (ROIC)
-0.93%-1.04%4.75%8.09%6.05%-5.71%
Upgrade
Return on Capital Employed (ROCE)
--14.70%20.70%23.40%-
Upgrade
Earnings Yield
-32.59%-40.47%10.59%49.54%35.49%-268.99%
Upgrade
FCF Yield
138.78%104.80%139.69%-61.19%-249.71%533.99%
Upgrade
Buyback Yield / Dilution
--0.11%2.50%-13.83%-
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.